Alzaabi, AshrafBell, John P.Montero-Arias, FeliciaPrice, David B.Jackson, David J.Wang, Hao-ChienBudgen, NigelFarouk, HishamMaslova, Ekaterina2023-09-112023-09-112023-11Alzaabi, A, Bell, J P, Montero-Arias, F, Price, D B, Jackson, D J, Wang, H-C, Budgen, N, Farouk, H & Maslova, E 2023, 'Greenhouse Gas Emissions from Respiratory Treatments : Results from the SABA CARBON International Study', Advances in Therapy, vol. 40, no. 11, pp. 4836-4856. https://doi.org/10.1007/s12325-023-02663-21865-8652RIS: urn:128B249197A6C73799F8A6AE185A9678RIS: Alzaabi2023https://hdl.handle.net/2164/21639Acknowledgements Medical Writing, Editorial, and Other Assistance Medical writing and editorial support were provided by Tejaswini Subbannayya, PhD, of Cactus Life Sciences (part of Cactus Communications, Mumbai, India), in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3). This support was fully funded by AstraZeneca. Funding AstraZeneca funded the study; was involved in the study design, protocol development, study conduct and statistical analysis; and was given the opportunity to review the manuscript before submission. AstraZeneca also funded medical writing support and the development of the graphical abstract. AstraZeneca funded the journal’s Rapid Service and Open Access fees.211313644engAsthmaAsthma controlcarbon footprintEnvironmental monitoringGreenhouse gas emissionsInhalersInhaler therapiesSABAShort-acting β2-agonistR MedicineSupplementary DataRJournal article10.1007/s12325-023-02663-24011